Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at ...

Naïve B cells exit quiescence and enter a proliferative state upon activation, ultimately differentiating into antibody-secreting or memory B cells. Toll-like receptor (TLR) ligands, such as ...

MDE pitched lawmakers on providing funding for more literacy and math coaches, another round of teacher pay raises, and ...

Mineral Resource Estimate Confirms Pitfield's World Dominant Titanium Discovery Empire Metals Ltd., the AIM-quoted and OTCQX-traded exploration and development company, is pleased to report a maiden ...